Whiteside TL - Search Results

1

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.

Butterfield LH, Palucka AK, Britten CM, Dhodapkar MV, Håkansson L, Janetzki S, Kawakami Y, Kleen TO, Lee PP, Maccalli C, Maecker HT, Maino VC, Maio M, Malyguine A, Masucci G, Pawelec G, Potter DM, Rivoltini L, Salazar LG, Schendel DJ, Slingluff CL Jr, Song W, Stroncek DF, Tahara H, Thurin M, Trinchieri G, van Der Burg SH, Whiteside TL, Wigginton JM, Marincola F, Khleif S, Fox BA, Disis ML. Butterfield LH, et al. Among authors: whiteside tl. Clin Cancer Res. 2011 May 15;17(10):3064-76. doi: 10.1158/1078-0432.CCR-10-2234. Epub 2011 May 10. Clin Cancer Res. 2011. PMID: 21558394 Free PMC article. Review.

2

Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.

Whiteside TL, Sung MW, Nagashima S, Chikamatsu K, Okada K, Vujanovic NL. Whiteside TL, et al. Clin Cancer Res. 1998 May;4(5):1135-45. Clin Cancer Res. 1998. PMID: 9607570

3

Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.

Myers JN, Yasumura S, Suminami Y, Hirabayashi H, Lin Wc, Johnson JT, Lotze MT, Whiteside TL. Myers JN, et al. Among authors: whiteside tl. Clin Cancer Res. 1996 Jan;2(1):127-35. Clin Cancer Res. 1996. PMID: 9816099

4

Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.

Rabinowich H, Banks M, Reichert TE, Logan TF, Kirkwood JM, Whiteside TL. Rabinowich H, et al. Among authors: whiteside tl. Clin Cancer Res. 1996 Aug;2(8):1263-74. Clin Cancer Res. 1996. PMID: 9816296

5

Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity.

Lotze MT, Shurin M, Esche C, Tahara H, Storkus W, Kirkwood JM, Whiteside TL, Elder EM, Okada H, Robbins P. Lotze MT, et al. Among authors: whiteside tl. Cancer J Sci Am. 2000 Feb;6 Suppl 1:S61-6. Cancer J Sci Am. 2000. PMID: 10685662 Review.

6

Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma.

Whiteside TL, Zhao Y, Tsukishiro T, Elder EM, Gooding W, Baar J. Whiteside TL, et al. Clin Cancer Res. 2003 Feb;9(2):641-9. Clin Cancer Res. 2003. PMID: 12576430 Clinical Trial.

7

Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.

Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL. Kuss I, et al. Among authors: whiteside tl. Clin Cancer Res. 2004 Jun 1;10(11):3755-62. doi: 10.1158/1078-0432.CCR-04-0054. Clin Cancer Res. 2004. PMID: 15173082

8

Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.

Kim JW, Tsukishiro T, Johnson JT, Whiteside TL. Kim JW, et al. Among authors: whiteside tl. Clin Cancer Res. 2004 Aug 1;10(15):5101-10. doi: 10.1158/1078-0432.CCR-04-0309. Clin Cancer Res. 2004. PMID: 15297413

9

Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.

Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, DeLeo A, Ferris RL. Sirianni N, et al. Among authors: whiteside tl. Clin Cancer Res. 2004 Oct 15;10(20):6929-37. doi: 10.1158/1078-0432.CCR-04-0672. Clin Cancer Res. 2004. PMID: 15501971

10

Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.

Lotze MT, Wang E, Marincola FM, Hanna N, Bugelski PJ, Burns CA, Coukos G, Damle N, Godfrey TE, Howell WM, Panelli MC, Perricone MA, Petricoin EF, Sauter G, Scheibenbogen C, Shivers SC, Taylor DL, Weinstein JN, Whiteside TL. Lotze MT, et al. Among authors: whiteside tl. J Immunother. 2005 Mar-Apr;28(2):79-119. doi: 10.1097/01.cji.0000154251.20125.2e. J Immunother. 2005. PMID: 15725954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

703 results

Search Page